Teleflex sells large portion of respiratory device unit to Medline for $286M

Teleflex has sold a significant portion of its respiratory device business to Medline for $286 million in cash, the company said June 28. 

Advertisement

The Wayne, Pa.-based devicemaker said the respiratory device product line generated $139 million in revenue in 2020. 

Teleflex expects a revenue headwind of $28 million to $32 million in 2021 as a result of the deal. The company said it intends to use money from the deal with Medline to pay down its debt and support growth. 

Read the full news release here. 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.